$1.030
+0.020 (+1.98%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de LCTX por análisis de gráficos similares
Alphio's LCTX stock price prediction model matches the current Lineage Cell Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.04 (+0.83%). The 1-week path is $1.01 (-1.90%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Lineage Cell Therapeutics Inc?
Lineage Cell Therapeutics Inc (LCTX) appears to be a good buy right now due to its current price of $1.01, which is near its 52-week low of $0.88, providing a favorable entry point. The company has shown a gross margin of 100% in the latest quarter, indicating strong profitability potential. However, the main risk is the projected forward P/E of 30.67, which suggests high expectations for future earnings growth that may not materialize.
LCTX cerró en $1.03 el Wednesday, tras subir +1.98%
Lineage Cell Therapeutics Inc (LCTX) last closed at $1.03, gaining +1.98%. These facts feed the 1-day and 1-week LCTX price prediction above.
Factores de la previsión
Los factores de la previsión de Lineage Cell Therapeutics Inc (LCTX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de LCTX, ordenadas por similitud.
Análisis de estacionalidad de LCTX
Historically the probability of a positive November return for LCTX is 45.24%. January offers the highest probability of a positive month at 72.13%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de LCTX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.99 | $1.10 | $1.33 | +6.80% |
| Dec 2026 | $1.09 | $1.34 | $1.35 | +29.81% |
En 2026, se proyecta que Lineage Cell Therapeutics Inc (LCTX) oscile entre $0.99 y $1.35.
Previsión mensual de Lineage Cell Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Lineage Cell Therapeutics Inc promedie $1.10, con un mínimo de $0.99 y un máximo de $1.33.
En Dec de 2026, se proyecta que Lineage Cell Therapeutics Inc promedie $1.34, con un mínimo de $1.09 y un máximo de $1.35.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.